Sangamo Therapeutics, Inc. (NASDAQ:SGMO) went up by 0.81% from its latest closing price when compared to the 1-year high value of $13.91 and move down -122.2%, while SGMO stocks collected +12.59% of gains with the last five trading sessions. Press Release reported on 03/02/20 that Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Worth an Investment?
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) The 36 Months beta value for SGMO stocks is at 2.04, while of the analysts out of 0 who provided ratings for Sangamo Therapeutics, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $20.67 which is $14.41 above current price. SGMO currently has a short float of 15.24% and public float of 115.01M with average trading volume of 2.35M shares.
SGMO Market Performance
SGMO stocks went up by 12.59% for the week, with the monthly drop of -7.94% and a quarterly performance of -30.06%, while its annual performance rate touched -33.40%. The simple moving average for the period of the last 20 days is -9.90% for SGMO stocks with the simple moving average of -33.42% for the last 200 days.
Analysts’ Opinion on Sangamo Therapeutics, Inc. (NASDAQ:SGMO)
Many brokerage firms have already submitted their reports for SGMO stocks, with H.C. Wainwright repeating the rating for SGMO shares by setting it to “Buy”. The predicted price for SGMO socks in the upcoming period according to H.C. Wainwright is $16 based on the research report published on August 26, 2019.
JP Morgan, on the other hand, stated in their research note that they expect to see SGMO stock at the price of $16. The rating they have provided for SGMO stocks is “Neutral” according to the report published on November 14, 2018.
Guggenheim gave “ Neutral” rating to SGMO stocks, setting the target price at $16 in the report published on November 9, 2018.
SGMO Stocks -15.36% Far from 50 Day Moving Average
After a stumble in the market that brought SGMO to its low price for the period of the last 52 weeks, Sangamo Therapeutics, Inc. was unable to take a rebound, for now settling with -55.00% of loss for the given period.
The stock volatility was left at 13.08%, however, within the period of a single month, the volatility rate increased by 13.03%, while the shares sank at the distance of -9.14% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -24.40% lower at the present time.
In the course of the last 5 trading sessions, SGMO went up by +12.59%, which changed the moving average for the period of 200 days to the total of -33.26% of losses for the stock in comparison to the 20-day moving average settled at $6.92. In addition, Sangamo Therapeutics, Inc. saw -25.21% in overturn over the period of a single year with a tendency to cut further losses.
SGMO Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Sangamo Therapeutics, Inc. (SGMO), starting from DILLY STEPHEN GEORGE, who sold 35,000 shares at the price of $6.00 back on Mar 19. After this action, Rushing now owns 5,000 shares of Sangamo Therapeutics, Inc., valued at $210,000 with the latest closing price.
PARKER H STEWART, the Director of Sangamo Therapeutics, Inc., bought 3,000 shares at the value of $5.20 during a trade that took place back on Mar 18, which means that PARKER H STEWART is holding 13,000 shares at the value of $15,585 based on the most recent closing price.
SGMO Stock Fundamentals
The current profitability levels are settled at -102.69 for the present operating margin. The net margin for Sangamo Therapeutics, Inc. stands at -92.93. Equity return holds the value -23.40%, with -15.30% for asset returns.